TABLE 1.
Action | Mechanism | References |
---|---|---|
Antiviral effects |
Inhibition of viral RNA polymerase, probably related to blockade of co‐factor phosphorylation through inhibition of GSK‐3β Protection of host cells from apoptosis triggered by viral infection |
Harrison et al., 2007; Asenjo et al., 2008 Ren et al., 2011 |
Immunomodulatory effects |
Inhibition of NF‐κB Inhibition of IL‐6 induced activation of STAT‐3, perhaps mediated through inhibition of GSK‐3β Inhibition of IL‐1β production Reduction in cyclooxygenase‐2 expression |
Troib & Azab, 2015 Beurel et al., 2010; Wang, Zhang, Li, et al., 2013; Minashima et al., 2014 Nassar & Azab, 2014 Nassar & Azab, 2014 |
Abbreviations: RNA, ribonucleic acid; GSK‐3β, glycogen synthase kinase—3 beta; NF‐κB, nuclear factor kappa B; STAT‐3, signal transducer and activator of transcription 3; IL‐6, interleukin‐6; IL‐1β, interleukin‐1 beta.